Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical Rheumatology
Published in: Clinical Rheumatology 1/2007

01-01-2007 | Case Report

Lupus erythematosus and lupus valgaris: a case report and historical remarks

Authors: Shuang Ye, Cheng-de Yang

Published in: Clinical Rheumatology | Issue 1/2007

Login to get access

Abstract

Lupus erythematosus and lupus valgaris, i.e., cutaneous tuberculosis, are confusing skin lesions in the history. Here, we reported on a Chinese lupus patient manifested with multiple nodular erythematous rashes on both upper extremities, which turned out to be cutaneous mycobacterial infection.
Literature
1.
Benedek TG (2001) Historical background of discoid and systemic lupus erythematosus. In: Wallace DJ, Hahn BH (eds) Dubois lupus erythematosus, 6th edn. Williams &Wilkins, Baltimore, pp 4–5
2.
Gordon MM, Wilson HE, Duthie FR et al (2002) When typical is atypical: mycobacterial infection mimicking cutaneous vasculitis. Rheumatology 41:685–690PubMedCrossRef
3.
Obermoser G, Zelger B, Zangerle R et al (2002) Extravascular necrotizing palisaded granulomas as the presenting skin sign of systemic lupus erythematosus. Br J Dermatol 147:371–374PubMedCrossRef
Metadata
Title
Lupus erythematosus and lupus valgaris: a case report and historical remarks
Authors
Shuang Ye
Cheng-de Yang
Publication date
01-01-2007
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 1/2007
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-005-0120-2

Other articles of this Issue 1/2007

Clinical Rheumatology 1/2007 Go to the issue

Case Report

Retroperitoneal fibrosis and c-ANCA positivity

Erratum

Spontaneous pneumomediastinum and dermatomyositis may be a not so rare association: report of a case and review of the literature

Case Report

Interstitial lung disease in a patient with antisynthetase syndrome and no myositis

Original Article

The frequency of thyroid antibodies in fibromyalgia patients and their relationship with symptoms

Letter to the Editor

Standardization is essential for a more rigorous comparison of rates: comment on the reply by Gilgil, Kacar, and Tuncer

Brief Report

Prognosis of polymyositis and dermatomyositis
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits